Education
About Us
Working with TipRanks
Follow Us
D.Western Therapeutics Institute, Inc. (JP:4576)
:4576
4576 Stock Chart & Stats
¥105.00
-¥3.00(-1.74%)
At close: 4:00 PM EST
¥105.00
-¥3.00(-1.74%)
Day’s Range― - ―
52-Week Range¥64.00 - ¥254.00
Previous CloseN/A
Volume3.18M
Average Volume (3M)7.54M
Market Cap
¥5.58B
Enterprise Value¥5.38B
Total Cash (Recent Filing)¥1.14B
Total Debt (Recent Filing)¥510.71M
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.67
Shares Outstanding53,139,713
10 Day Avg. Volume889,800
30 Day Avg. Volume7,540,506
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
D.Western Therapeutics Institute News
4576 FAQ
What was D.Western Therapeutics Institute, Inc.’s price range in the past 12 months?
D.Western Therapeutics Institute, Inc. lowest stock price was ¥64.00 and its highest was ¥254.00 in the past 12 months.
What is D.Western Therapeutics Institute, Inc.’s market cap?
D.Western Therapeutics Institute, Inc.’s market cap is ¥5.58B.
When is D.Western Therapeutics Institute, Inc.’s upcoming earnings report date?
D.Western Therapeutics Institute, Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 22 days.
How were D.Western Therapeutics Institute, Inc.’s earnings last quarter?
D.Western Therapeutics Institute, Inc. released its earnings results on Aug 14, 2025. The company reported -¥3.67 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.67.
Is D.Western Therapeutics Institute, Inc. overvalued?
According to Wall Street analysts D.Western Therapeutics Institute, Inc.’s price is currently Overvalued.
Does D.Western Therapeutics Institute, Inc. pay dividends?
D.Western Therapeutics Institute, Inc. does not currently pay dividends.
What is D.Western Therapeutics Institute, Inc.’s EPS estimate?
D.Western Therapeutics Institute, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does D.Western Therapeutics Institute, Inc. have?
D.Western Therapeutics Institute, Inc. has 53,139,713 shares outstanding.
What happened to D.Western Therapeutics Institute, Inc.’s price movement after its last earnings report?
D.Western Therapeutics Institute, Inc. reported an EPS of -¥3.67 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.478%.
Which hedge fund is a major shareholder of D.Western Therapeutics Institute, Inc.?
Currently, no hedge funds are holding shares in JP:4576
Company Description
D.Western Therapeutics Institute, Inc.
D.Western Therapeutics Institute (4576) is a biotechnology company focused on developing innovative therapeutic solutions for various medical conditions. Operating primarily in the healthcare sector, the company specializes in research and development of biologics and small-molecule drugs aimed at treating chronic diseases, particularly in oncology and autoimmune disorders. With a commitment to advancing science and improving patient outcomes, D.Western Therapeutics Institute leverages cutting-edge technology and extensive clinical research to create effective treatment options.
Technical Analysis
OncoTherapy Science
―
Immuno-Biological Laboratories Co., Ltd.
―
Delta-Fly Pharma, Inc.
―
FunPep Company Limited
―
Kringle Pharma, Inc.
―